Sanofi to Lay Off 229 Workers in Massachusetts Following Acquisition

Sanofi, a significant pharmaceutical employer in Massachusetts, will be laying off 229 workers. This decision comes after Sanofi acquired Blueprint Medicines, a Cambridge-based biotech, in a $9.1 billion deal in July 2025.

The layoffs will affect workers employed with Blueprint Medicines, with positions being cut between October 9 and late June 2027. Sanofi filed the necessary records with the state's Executive Office of Labor and Workforce Development.

The acquisition of Blueprint Medicines by Sanofi has led to these layoffs, as the company reorganizes its workforce. The exact reasons behind the layoffs are not specified in the filing.

The layoffs are a result of Sanofi's efforts to integrate Blueprint Medicines into its operations. The company is likely looking to streamline its workforce and reduce costs.

The layoffs will have a significant impact on the workers who will be losing their jobs. Sanofi will need to provide support to these employees during this transition period.

## Layoffs Timeline

The layoffs will take place between October 9 and late June 2027. This timeline will give Sanofi ample time to reorganize its workforce and minimize disruptions to its operations.

## Impact on Workers

The layoffs will have a significant impact on the workers who will be losing their jobs. Sanofi will need to provide support to these employees during this transition period. The company will need to ensure that the affected workers receive the necessary resources and assistance to help them navigate this change.

## Conclusion

The layoffs at Sanofi are a result of the company's efforts to integrate Blueprint Medicines into its operations. The exact reasons behind the layoffs are not specified in the filing. However, it is clear that the acquisition of Blueprint Medicines has led to these layoffs, as Sanofi reorganizes its workforce to reduce costs and streamline its operations.